| Dr Glenn Sariol, MD | |
|
515 Wekiva Commons Cir, Apopka, FL 32712-3645 | |
| (407) 464-9516 | |
| (407) 464-9519 |
| Full Name | Dr Glenn Sariol |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 20 Years |
| Location | 515 Wekiva Commons Cir, Apopka, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083004709 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Adventhealth Heart Of Florida | Davenport, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Florida Hospitalist Partners Pa | 5799689931 | 81 |
News Archive
Even patients with insurance are finding that specialty drugs can quickly eat a hole in their wallets because insurers are often putting them in a special tier and demanding high consumer co-payments. Also, the State Department is getting rid of the "transgender exclusion" in it largest health plan, and some consumer advocates are suggesting that people getting coverage on the health marketplaces be allowed to get "wrap-around" plans through their employers.
Pulmonary fibrosis is a scarring or thickening of the lungs that causes shortness of breath, a dry cough, fatigue, chest discomfort, weight loss, a decrease in the ability of the lungs to transmit oxygen to the blood stream, and, eventually, heart failure.
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
One in five patients is prescribed opioids after having a pacemaker or similar device implanted, according to a large US study conducted at Mayo Clinic published in HeartRhythm, the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society published by Elsevier.
Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.
› Verified 8 days ago
| Entity Name | Central Florida Hospitalist Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558381921 PECOS PAC ID: 5799689931 Enrollment ID: O20031120000518 |
News Archive
Even patients with insurance are finding that specialty drugs can quickly eat a hole in their wallets because insurers are often putting them in a special tier and demanding high consumer co-payments. Also, the State Department is getting rid of the "transgender exclusion" in it largest health plan, and some consumer advocates are suggesting that people getting coverage on the health marketplaces be allowed to get "wrap-around" plans through their employers.
Pulmonary fibrosis is a scarring or thickening of the lungs that causes shortness of breath, a dry cough, fatigue, chest discomfort, weight loss, a decrease in the ability of the lungs to transmit oxygen to the blood stream, and, eventually, heart failure.
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
One in five patients is prescribed opioids after having a pacemaker or similar device implanted, according to a large US study conducted at Mayo Clinic published in HeartRhythm, the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society published by Elsevier.
Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glenn Sariol, MD 515 Wekiva Commons Cir, Apopka, FL 32712-3645 Ph: (407) 464-9516 | Dr Glenn Sariol, MD 515 Wekiva Commons Cir, Apopka, FL 32712-3645 Ph: (407) 464-9516 |
News Archive
Even patients with insurance are finding that specialty drugs can quickly eat a hole in their wallets because insurers are often putting them in a special tier and demanding high consumer co-payments. Also, the State Department is getting rid of the "transgender exclusion" in it largest health plan, and some consumer advocates are suggesting that people getting coverage on the health marketplaces be allowed to get "wrap-around" plans through their employers.
Pulmonary fibrosis is a scarring or thickening of the lungs that causes shortness of breath, a dry cough, fatigue, chest discomfort, weight loss, a decrease in the ability of the lungs to transmit oxygen to the blood stream, and, eventually, heart failure.
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
One in five patients is prescribed opioids after having a pacemaker or similar device implanted, according to a large US study conducted at Mayo Clinic published in HeartRhythm, the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society published by Elsevier.
Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.
› Verified 8 days ago
Yorlenis Rodriguez, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 N Park Ave, Apopka, FL 32703 Phone: 407-889-1953 | |
Ramiro Zurita, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 | |
Dr. Louis Padgett, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9519 Fax: 407-464-9519 | |
Dr. Bolanle Akakabota, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 | |
Zaid Tabbaa, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 | |
Leah Delumpa, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 | |
Dr. Soheil Peiman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 |